Type 2 Diabetes Mellitus Therapeutics Market 2022 Type 2 Diabetes Mellitus Therapeutics Market 2022 Zum Anzeigen klicken
  • Kommentare

Type 2 Diabetes Mellitus Therapeutics Market 2022

Type 2 Diabetes Mellitus Therapeutics Market 2022

Veröffentlicht am in "Business", Sprache — English. 6 Seiten.
The current South-East Asia T2DM market contains novel products, including Jardiance, a SGLT-2 inhibitor; Victoza, a GLP-1 receptor agonist; and Januvia, a DPP-4 inhibitor. Mehr anzeigen
KOSTENLOSES Abonnement